Global Drug-Eluting Bioabsorbable Stents Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Drug-Eluting Bioabsorbable Stents Market Size was estimated at USD 936.80 million in 2023 and is projected to reach USD 1219.96 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Drug-Eluting Bioabsorbable Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Bioabsorbable Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Bioabsorbable Stents market in any manner.
Global Drug-Eluting Bioabsorbable Stents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Market Segmentation (by Type)
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Market Segmentation (by Application)
Coronary Artery Diseases
Peripheral Artery Diseases
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Bioabsorbable Stents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Drug-Eluting Bioabsorbable Stents Market Size was estimated at USD 936.80 million in 2023 and is projected to reach USD 1219.96 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Drug-Eluting Bioabsorbable Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Bioabsorbable Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Bioabsorbable Stents market in any manner.
Global Drug-Eluting Bioabsorbable Stents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Market Segmentation (by Type)
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Market Segmentation (by Application)
Coronary Artery Diseases
Peripheral Artery Diseases
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug-Eluting Bioabsorbable Stents Market
- Overview of the regional outlook of the Drug-Eluting Bioabsorbable Stents Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Bioabsorbable Stents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug-Eluting Bioabsorbable Stents
1.2 Key Market Segments
1.2.1 Drug-Eluting Bioabsorbable Stents Segment by Type
1.2.2 Drug-Eluting Bioabsorbable Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG-ELUTING BIOABSORBABLE STENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG-ELUTING BIOABSORBABLE STENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2019-2024)
3.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Eluting Bioabsorbable Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Eluting Bioabsorbable Stents Sales Sites, Area Served, Product Type
3.6 Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends
3.6.1 Drug-Eluting Bioabsorbable Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG-ELUTING BIOABSORBABLE STENTS INDUSTRY CHAIN ANALYSIS
4.1 Drug-Eluting Bioabsorbable Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG-ELUTING BIOABSORBABLE STENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2019-2024)
6.3 Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Eluting Bioabsorbable Stents Price by Type (2019-2024)
7 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Bioabsorbable Stents Market Sales by Application (2019-2024)
7.3 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2019-2024)
8 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY REGION
8.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Eluting Bioabsorbable Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic
9.1.1 Medtronic Drug-Eluting Bioabsorbable Stents Basic Information
9.1.2 Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
9.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product Market Performance
9.1.4 Medtronic Business Overview
9.1.5 Medtronic Drug-Eluting Bioabsorbable Stents SWOT Analysis
9.1.6 Medtronic Recent Developments
9.2 B.Braun Melsungen
9.2.1 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Basic Information
9.2.2 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
9.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Market Performance
9.2.4 B.Braun Melsungen Business Overview
9.2.5 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents SWOT Analysis
9.2.6 B.Braun Melsungen Recent Developments
9.3 Abbott Laboratories
9.3.1 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Basic Information
9.3.2 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
9.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Market Performance
9.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents SWOT Analysis
9.3.5 Abbott Laboratories Business Overview
9.3.6 Abbott Laboratories Recent Developments
9.4 Boston Scientific Corporation
9.4.1 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
9.4.2 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
9.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
9.4.4 Boston Scientific Corporation Business Overview
9.4.5 Boston Scientific Corporation Recent Developments
9.5 Biosensors International
9.5.1 Biosensors International Drug-Eluting Bioabsorbable Stents Basic Information
9.5.2 Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
9.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product Market Performance
9.5.4 Biosensors International Business Overview
9.5.5 Biosensors International Recent Developments
9.6 Terumo Corporation.
9.6.1 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Basic Information
9.6.2 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
9.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Market Performance
9.6.4 Terumo Corporation. Business Overview
9.6.5 Terumo Corporation. Recent Developments
9.7 MicroPort Scientific Corporation
9.7.1 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
9.7.2 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
9.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
9.7.4 MicroPort Scientific Corporation Business Overview
9.7.5 MicroPort Scientific Corporation Recent Developments
9.8 Alvimedica
9.8.1 Alvimedica Drug-Eluting Bioabsorbable Stents Basic Information
9.8.2 Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
9.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product Market Performance
9.8.4 Alvimedica Business Overview
9.8.5 Alvimedica Recent Developments
9.9 Biotronik
9.9.1 Biotronik Drug-Eluting Bioabsorbable Stents Basic Information
9.9.2 Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
9.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product Market Performance
9.9.4 Biotronik Business Overview
9.9.5 Biotronik Recent Developments
9.10 Elixir Medical Corporation
9.10.1 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Basic Information
9.10.2 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
9.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
9.10.4 Elixir Medical Corporation Business Overview
9.10.5 Elixir Medical Corporation Recent Developments
9.11 Innovative Health Technologies
9.11.1 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Basic Information
9.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
9.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Market Performance
9.11.4 Innovative Health Technologies Business Overview
9.11.5 Innovative Health Technologies Recent Developments
10 DRUG-ELUTING BIOABSORBABLE STENTS MARKET FORECAST BY REGION
10.1 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast
10.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region
10.2.4 South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Eluting Bioabsorbable Stents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Type (2025-2030)
11.1.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Eluting Bioabsorbable Stents by Type (2025-2030)
11.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application
11.2.2 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug-Eluting Bioabsorbable Stents
1.2 Key Market Segments
1.2.1 Drug-Eluting Bioabsorbable Stents Segment by Type
1.2.2 Drug-Eluting Bioabsorbable Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG-ELUTING BIOABSORBABLE STENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG-ELUTING BIOABSORBABLE STENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2019-2024)
3.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Eluting Bioabsorbable Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Eluting Bioabsorbable Stents Sales Sites, Area Served, Product Type
3.6 Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends
3.6.1 Drug-Eluting Bioabsorbable Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG-ELUTING BIOABSORBABLE STENTS INDUSTRY CHAIN ANALYSIS
4.1 Drug-Eluting Bioabsorbable Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG-ELUTING BIOABSORBABLE STENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2019-2024)
6.3 Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Eluting Bioabsorbable Stents Price by Type (2019-2024)
7 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Bioabsorbable Stents Market Sales by Application (2019-2024)
7.3 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2019-2024)
8 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY REGION
8.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Eluting Bioabsorbable Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic
9.1.1 Medtronic Drug-Eluting Bioabsorbable Stents Basic Information
9.1.2 Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
9.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product Market Performance
9.1.4 Medtronic Business Overview
9.1.5 Medtronic Drug-Eluting Bioabsorbable Stents SWOT Analysis
9.1.6 Medtronic Recent Developments
9.2 B.Braun Melsungen
9.2.1 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Basic Information
9.2.2 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
9.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Market Performance
9.2.4 B.Braun Melsungen Business Overview
9.2.5 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents SWOT Analysis
9.2.6 B.Braun Melsungen Recent Developments
9.3 Abbott Laboratories
9.3.1 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Basic Information
9.3.2 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
9.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Market Performance
9.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents SWOT Analysis
9.3.5 Abbott Laboratories Business Overview
9.3.6 Abbott Laboratories Recent Developments
9.4 Boston Scientific Corporation
9.4.1 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
9.4.2 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
9.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
9.4.4 Boston Scientific Corporation Business Overview
9.4.5 Boston Scientific Corporation Recent Developments
9.5 Biosensors International
9.5.1 Biosensors International Drug-Eluting Bioabsorbable Stents Basic Information
9.5.2 Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
9.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product Market Performance
9.5.4 Biosensors International Business Overview
9.5.5 Biosensors International Recent Developments
9.6 Terumo Corporation.
9.6.1 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Basic Information
9.6.2 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
9.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Market Performance
9.6.4 Terumo Corporation. Business Overview
9.6.5 Terumo Corporation. Recent Developments
9.7 MicroPort Scientific Corporation
9.7.1 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
9.7.2 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
9.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
9.7.4 MicroPort Scientific Corporation Business Overview
9.7.5 MicroPort Scientific Corporation Recent Developments
9.8 Alvimedica
9.8.1 Alvimedica Drug-Eluting Bioabsorbable Stents Basic Information
9.8.2 Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
9.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product Market Performance
9.8.4 Alvimedica Business Overview
9.8.5 Alvimedica Recent Developments
9.9 Biotronik
9.9.1 Biotronik Drug-Eluting Bioabsorbable Stents Basic Information
9.9.2 Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
9.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product Market Performance
9.9.4 Biotronik Business Overview
9.9.5 Biotronik Recent Developments
9.10 Elixir Medical Corporation
9.10.1 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Basic Information
9.10.2 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
9.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
9.10.4 Elixir Medical Corporation Business Overview
9.10.5 Elixir Medical Corporation Recent Developments
9.11 Innovative Health Technologies
9.11.1 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Basic Information
9.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
9.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Market Performance
9.11.4 Innovative Health Technologies Business Overview
9.11.5 Innovative Health Technologies Recent Developments
10 DRUG-ELUTING BIOABSORBABLE STENTS MARKET FORECAST BY REGION
10.1 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast
10.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region
10.2.4 South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Eluting Bioabsorbable Stents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Type (2025-2030)
11.1.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Eluting Bioabsorbable Stents by Type (2025-2030)
11.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application
11.2.2 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Eluting Bioabsorbable Stents Market Size Comparison by Region (M USD)
Table 5. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug-Eluting Bioabsorbable Stents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2022)
Table 10. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug-Eluting Bioabsorbable Stents Sales Sites and Area Served
Table 12. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
Table 13. Global Drug-Eluting Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug-Eluting Bioabsorbable Stents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Eluting Bioabsorbable Stents Market Challenges
Table 22. Global Drug-Eluting Bioabsorbable Stents Sales by Type (K Units)
Table 23. Global Drug-Eluting Bioabsorbable Stents Market Size by Type (M USD)
Table 24. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2019-2024)
Table 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2019-2024)
Table 26. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug-Eluting Bioabsorbable Stents Market Size Share by Type (2019-2024)
Table 28. Global Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Type (2019-2024)
Table 29. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application
Table 30. Global Drug-Eluting Bioabsorbable Stents Market Size by Application
Table 31. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2019-2024) & (K Units)
Table 32. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2019-2024)
Table 33. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2019-2024)
Table 35. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2019-2024) & (K Units)
Table 37. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2019-2024)
Table 38. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2024) & (K Units)
Table 39. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2019-2024) & (K Units)
Table 41. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region (2019-2024) & (K Units)
Table 43. Medtronic Drug-Eluting Bioabsorbable Stents Basic Information
Table 44. Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
Table 45. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Medtronic Business Overview
Table 47. Medtronic Drug-Eluting Bioabsorbable Stents SWOT Analysis
Table 48. Medtronic Recent Developments
Table 49. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Basic Information
Table 50. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
Table 51. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. B.Braun Melsungen Business Overview
Table 53. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents SWOT Analysis
Table 54. B.Braun Melsungen Recent Developments
Table 55. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Basic Information
Table 56. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
Table 57. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbott Laboratories Drug-Eluting Bioabsorbable Stents SWOT Analysis
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Recent Developments
Table 61. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
Table 62. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 63. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Boston Scientific Corporation Business Overview
Table 65. Boston Scientific Corporation Recent Developments
Table 66. Biosensors International Drug-Eluting Bioabsorbable Stents Basic Information
Table 67. Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
Table 68. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Biosensors International Business Overview
Table 70. Biosensors International Recent Developments
Table 71. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Basic Information
Table 72. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
Table 73. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Terumo Corporation. Business Overview
Table 75. Terumo Corporation. Recent Developments
Table 76. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
Table 77. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 78. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. MicroPort Scientific Corporation Business Overview
Table 80. MicroPort Scientific Corporation Recent Developments
Table 81. Alvimedica Drug-Eluting Bioabsorbable Stents Basic Information
Table 82. Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
Table 83. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Alvimedica Business Overview
Table 85. Alvimedica Recent Developments
Table 86. Biotronik Drug-Eluting Bioabsorbable Stents Basic Information
Table 87. Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
Table 88. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Biotronik Business Overview
Table 90. Biotronik Recent Developments
Table 91. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Basic Information
Table 92. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 93. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Elixir Medical Corporation Business Overview
Table 95. Elixir Medical Corporation Recent Developments
Table 96. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Basic Information
Table 97. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
Table 98. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Innovative Health Technologies Business Overview
Table 100. Innovative Health Technologies Recent Developments
Table 101. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Drug-Eluting Bioabsorbable Stents Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Drug-Eluting Bioabsorbable Stents Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Eluting Bioabsorbable Stents Market Size Comparison by Region (M USD)
Table 5. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug-Eluting Bioabsorbable Stents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2022)
Table 10. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug-Eluting Bioabsorbable Stents Sales Sites and Area Served
Table 12. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
Table 13. Global Drug-Eluting Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug-Eluting Bioabsorbable Stents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Eluting Bioabsorbable Stents Market Challenges
Table 22. Global Drug-Eluting Bioabsorbable Stents Sales by Type (K Units)
Table 23. Global Drug-Eluting Bioabsorbable Stents Market Size by Type (M USD)
Table 24. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2019-2024)
Table 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2019-2024)
Table 26. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug-Eluting Bioabsorbable Stents Market Size Share by Type (2019-2024)
Table 28. Global Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Type (2019-2024)
Table 29. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application
Table 30. Global Drug-Eluting Bioabsorbable Stents Market Size by Application
Table 31. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2019-2024) & (K Units)
Table 32. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2019-2024)
Table 33. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2019-2024)
Table 35. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2019-2024) & (K Units)
Table 37. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2019-2024)
Table 38. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2024) & (K Units)
Table 39. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2019-2024) & (K Units)
Table 41. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region (2019-2024) & (K Units)
Table 43. Medtronic Drug-Eluting Bioabsorbable Stents Basic Information
Table 44. Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
Table 45. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Medtronic Business Overview
Table 47. Medtronic Drug-Eluting Bioabsorbable Stents SWOT Analysis
Table 48. Medtronic Recent Developments
Table 49. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Basic Information
Table 50. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
Table 51. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. B.Braun Melsungen Business Overview
Table 53. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents SWOT Analysis
Table 54. B.Braun Melsungen Recent Developments
Table 55. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Basic Information
Table 56. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
Table 57. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbott Laboratories Drug-Eluting Bioabsorbable Stents SWOT Analysis
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Recent Developments
Table 61. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
Table 62. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 63. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Boston Scientific Corporation Business Overview
Table 65. Boston Scientific Corporation Recent Developments
Table 66. Biosensors International Drug-Eluting Bioabsorbable Stents Basic Information
Table 67. Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
Table 68. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Biosensors International Business Overview
Table 70. Biosensors International Recent Developments
Table 71. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Basic Information
Table 72. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
Table 73. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Terumo Corporation. Business Overview
Table 75. Terumo Corporation. Recent Developments
Table 76. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Basic Information
Table 77. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 78. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. MicroPort Scientific Corporation Business Overview
Table 80. MicroPort Scientific Corporation Recent Developments
Table 81. Alvimedica Drug-Eluting Bioabsorbable Stents Basic Information
Table 82. Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
Table 83. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Alvimedica Business Overview
Table 85. Alvimedica Recent Developments
Table 86. Biotronik Drug-Eluting Bioabsorbable Stents Basic Information
Table 87. Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
Table 88. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Biotronik Business Overview
Table 90. Biotronik Recent Developments
Table 91. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Basic Information
Table 92. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 93. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Elixir Medical Corporation Business Overview
Table 95. Elixir Medical Corporation Recent Developments
Table 96. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Basic Information
Table 97. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
Table 98. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Innovative Health Technologies Business Overview
Table 100. Innovative Health Technologies Recent Developments
Table 101. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Drug-Eluting Bioabsorbable Stents Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Drug-Eluting Bioabsorbable Stents Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drug-Eluting Bioabsorbable Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD), 2019-2030
Figure 5. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) (2019-2030)
Figure 6. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Eluting Bioabsorbable Stents Market Size by Country (M USD)
Figure 11. Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers in 2023
Figure 12. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers in 2023
Figure 13. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug-Eluting Bioabsorbable Stents Market Share by Type
Figure 18. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type (2019-2024)
Figure 19. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type in 2023
Figure 20. Market Size Share of Drug-Eluting Bioabsorbable Stents by Type (2019-2024)
Figure 21. Market Size Market Share of Drug-Eluting Bioabsorbable Stents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug-Eluting Bioabsorbable Stents Market Share by Application
Figure 24. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2019-2024)
Figure 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2023
Figure 26. Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2019-2024)
Figure 27. Global Drug-Eluting Bioabsorbable Stents Market Share by Application in 2023
Figure 28. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2019-2024)
Figure 30. North America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2023
Figure 32. U.S. Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Drug-Eluting Bioabsorbable Stents Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Drug-Eluting Bioabsorbable Stents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2023
Figure 37. Germany Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2023
Figure 44. China Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 50. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2023
Figure 51. Brazil Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2025-2030)
Figure 66. Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Drug-Eluting Bioabsorbable Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD), 2019-2030
Figure 5. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) (2019-2030)
Figure 6. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Eluting Bioabsorbable Stents Market Size by Country (M USD)
Figure 11. Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers in 2023
Figure 12. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers in 2023
Figure 13. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug-Eluting Bioabsorbable Stents Market Share by Type
Figure 18. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type (2019-2024)
Figure 19. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type in 2023
Figure 20. Market Size Share of Drug-Eluting Bioabsorbable Stents by Type (2019-2024)
Figure 21. Market Size Market Share of Drug-Eluting Bioabsorbable Stents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug-Eluting Bioabsorbable Stents Market Share by Application
Figure 24. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2019-2024)
Figure 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2023
Figure 26. Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2019-2024)
Figure 27. Global Drug-Eluting Bioabsorbable Stents Market Share by Application in 2023
Figure 28. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2019-2024)
Figure 30. North America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2023
Figure 32. U.S. Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Drug-Eluting Bioabsorbable Stents Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Drug-Eluting Bioabsorbable Stents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2023
Figure 37. Germany Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2023
Figure 44. China Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 50. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2023
Figure 51. Brazil Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2025-2030)
Figure 66. Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Application (2025-2030)
